Kingsview Wealth Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Kingsview Wealth Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,294	Closed	-$498K	–	1034
2021 Q1	$498K	Buy	+2,294	New	+$431K	0.03%	506
2020 Q3	–	Sell	-1,684	Closed	-$207K	–	719
2020 Q2	$207K	Buy	+1,684	New	+$191K	0.02%	528
2020 Q1	–	Sell	-2,708	Closed	-$283K	–	589
2019 Q4	$283K	Buy	+2,708	New	+$304K	0.04%	377

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Kingsview Wealth Management's GWPH Position: Q2 2021 in Review

Kingsview Wealth Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 2,294 shares — an estimated $498K sold.

Kingsview Wealth Management first reported a position in GWPH in Q4 2019 and held it in 3 quarters. The position peaked at $498K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Kingsview Wealth Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Kingsview Wealth Management sold 2,294 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $498K.
Kingsview Wealth Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 3 quarters.
Kingsview Wealth Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $498K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Kingsview Wealth Management's 13F filing for Q2 2021, filed 17 Aug 2021.